Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 96

1.

Smarcc1 expression: a significant predictor of disease-specific survival in patients with clinically localized prostate cancer treated with no intention to cure.

Hansen RL, Heeboll S, Ottosen PD, Dyrskjøt L, Borre M.

Scand J Urol Nephrol. 2011 Mar;45(2):91-6. doi: 10.3109/00365599.2010.530295. Epub 2010 Nov 18.

PMID:
21087120
[PubMed - indexed for MEDLINE]
2.

SMARCC1 expression is upregulated in prostate cancer and positively correlated with tumour recurrence and dedifferentiation.

Heebøll S, Borre M, Ottosen PD, Andersen CL, Mansilla F, Dyrskjøt L, Orntoft TF, Tørring N.

Histol Histopathol. 2008 Sep;23(9):1069-76.

PMID:
18581278
[PubMed - indexed for MEDLINE]
3.

Independent prognostic significance of HER-2 oncoprotein expression in pN0 prostate cancer undergoing curative radiotherapy.

Fosså A, Lilleby W, Fosså SD, Gaudernack G, Torlakovic G, Berner A.

Int J Cancer. 2002 May 1;99(1):100-5.

PMID:
11948499
[PubMed - indexed for MEDLINE]
4.

ERG immunohistochemistry is not predictive for PSA recurrence, local recurrence or overall survival after radical prostatectomy for prostate cancer.

Hoogland AM, Jenster G, van Weerden WM, Trapman J, van der Kwast T, Roobol MJ, Schröder FH, Wildhagen MF, van Leenders GJ.

Mod Pathol. 2012 Mar;25(3):471-9. doi: 10.1038/modpathol.2011.176. Epub 2011 Nov 11.

PMID:
22080055
[PubMed - indexed for MEDLINE]
Free Article
5.

Tissue microarray analysis of hMSH2 expression predicts outcome in men with prostate cancer.

Prtilo A, Leach FS, Markwalder R, Kappeler A, Burkhard FC, Cecchini MG, Studer UE, Thalmann GN.

J Urol. 2005 Nov;174(5):1814-8; discussion 1818.

PMID:
16217293
[PubMed - indexed for MEDLINE]
6.

Elevated levels of apoptosis regulator proteins p53 and bcl-2 are independent prognostic biomarkers in surgically treated clinically localized prostate cancer.

Bauer JJ, Sesterhenn IA, Mostofi FK, McLeod DG, Srivastava S, Moul JW.

J Urol. 1996 Oct;156(4):1511-6.

PMID:
8808919
[PubMed - indexed for MEDLINE]
7.

Low p27 expression predicts poor disease-free survival in patients with prostate cancer.

Yang RM, Naitoh J, Murphy M, Wang HJ, Phillipson J, deKernion JB, Loda M, Reiter RE.

J Urol. 1998 Mar;159(3):941-5.

PMID:
9474188
[PubMed - indexed for MEDLINE]
8.

p53, bcl-2 and retinoblastoma proteins as long-term prognostic markers in localized carcinoma of the prostate.

Theodorescu D, Broder SR, Boyd JC, Mills SE, Frierson HF Jr.

J Urol. 1997 Jul;158(1):131-7.

PMID:
9186339
[PubMed - indexed for MEDLINE]
9.

Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.

Ploussard G, Agamy MA, Alenda O, Allory Y, Mouracade P, Vordos D, Hoznek A, Abbou CC, de la Taille A, Salomon L.

BJU Int. 2011 Jun;107(11):1748-54. doi: 10.1111/j.1464-410X.2010.09728.x. Epub 2010 Sep 30.

PMID:
20883488
[PubMed - indexed for MEDLINE]
10.

Androgen receptor expression in prostate cancer lymph node metastases is predictive of outcome after surgery.

Sweat SD, Pacelli A, Bergstralh EJ, Slezak JM, Cheng L, Bostwick DG.

J Urol. 1999 Apr;161(4):1233-7.

PMID:
10081876
[PubMed - indexed for MEDLINE]
11.

XPA-210: a new proliferation marker determines locally advanced prostate cancer and is a predictor of biochemical recurrence.

Aufderklamm S, Hennenlotter J, Todenhoefer T, Gakis G, Schilling D, Vogel U, Kuehs U, Dlugosch J, Knapp J, Merseburger A, Gerber V, Ordelheide A, Hevler J, Stenzl A, Schwentner C.

World J Urol. 2012 Aug;30(4):547-52. doi: 10.1007/s00345-011-0768-y. Epub 2011 Oct 4.

PMID:
21969130
[PubMed - indexed for MEDLINE]
12.

Low AZGP1 expression predicts for recurrence in margin-positive, localized prostate cancer.

Yip PY, Kench JG, Rasiah KK, Benito RP, Lee CS, Stricker PD, Henshall SM, Sutherland RL, Horvath LG.

Prostate. 2011 Nov;71(15):1638-45. doi: 10.1002/pros.21381. Epub 2011 Mar 22.

PMID:
21432866
[PubMed - indexed for MEDLINE]
13.

Early prostate-specific antigen relapse after radical retropubic prostatectomy: prediction on the basis of preoperative and postoperative tumor characteristics.

Graefen M, Noldus J, Pichlmeier U, Haese A, Hammerer P, Fernandez S, Conrad S, Henke R, Huland E, Huland H.

Eur Urol. 1999;36(1):21-30.

PMID:
10364651
[PubMed - indexed for MEDLINE]
14.

Clinical significance of p53 alterations in surgically treated prostate cancers.

Schlomm T, Iwers L, Kirstein P, Jessen B, Köllermann J, Minner S, Passow-Drolet A, Mirlacher M, Milde-Langosch K, Graefen M, Haese A, Steuber T, Simon R, Huland H, Sauter G, Erbersdobler A.

Mod Pathol. 2008 Nov;21(11):1371-8. doi: 10.1038/modpathol.2008.104. Epub 2008 Jun 13.

PMID:
18552821
[PubMed - indexed for MEDLINE]
Free Article
15.

Protein expression of p53, bcl-2, and KI-67 (MIB-1) as prognostic biomarkers in patients with surgically treated, clinically localized prostate cancer.

Moul JW, Bettencourt MC, Sesterhenn IA, Mostofi FK, McLeod DG, Srivastava S, Bauer JJ.

Surgery. 1996 Aug;120(2):159-66; discussion 166-7.

PMID:
8751578
[PubMed - indexed for MEDLINE]
16.

Overexpression of vasoactive intestinal peptide receptors and cyclooxygenase-2 in human prostate cancer. Analysis of potential prognostic relevance.

Fernández-Martínez AB, Carmena MJ, Arenas MI, Bajo AM, Prieto JC, Sánchez-Chapado M.

Histol Histopathol. 2012 Aug;27(8):1093-101.

PMID:
22763881
[PubMed - indexed for MEDLINE]
17.

Prognostic value of connexin43 expression in patients with clinically localized prostate cancer.

Benko G, Spajić B, Demirović A, Stimac G, Kru Sbreve Lin B, Tomas D.

Prostate Cancer Prostatic Dis. 2011 Mar;14(1):90-5. doi: 10.1038/pcan.2010.51. Epub 2010 Dec 21.

PMID:
21173791
[PubMed - indexed for MEDLINE]
18.

Predictive value of altered p27Kip1 and p21WAF/Cip1 protein expression for the clinical prognosis of patients with localized prostate cancer.

Kuczyk MA, Bokemeyer C, Hartmann J, Schubach J, Walter C, Machtens S, Knuchel R, Kollmannsberger C, Jonas U, Serth J.

Oncol Rep. 2001 Nov-Dec;8(6):1401-7.

PMID:
11605074
[PubMed - indexed for MEDLINE]
19.
20.

Association of p27Kip1 levels with recurrence and survival in patients with stage C prostate carcinoma.

Cote RJ, Shi Y, Groshen S, Feng AC, Cordon-Cardo C, Skinner D, Lieskovosky G.

J Natl Cancer Inst. 1998 Jun 17;90(12):916-20.

PMID:
9637141
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk